Isocitrate Dehydrogenase 3 (NAD+) beta (IDH3B) (C-Term) Peptide
Quick Overview for Isocitrate Dehydrogenase 3 (NAD+) beta (IDH3B) (C-Term) Peptide (ABIN2185503)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- YMTRHNNLDL VIIREQTEGE YSSLEHEVRP QKLGEGKDED GREVELLVSL
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-IDH3B Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- IDH3B (Isocitrate Dehydrogenase 3 (NAD+) beta (IDH3B))
-
Background
-
The function of this protein remains unknown.
Protein Size: 204 -
Molecular Weight
- 22 kDa
-
UniProt
- L0R875
Target
-